Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Medpace Holdings Inc (MEDP) vs SoFi Technologies Inc (SOFI) Price & Performance

Medpace Holdings IncTrade
SoFi Technologies IncTrade

Price performance (Past 24H)

Key statistics

Medpace Holdings Inc vs SoFi Technologies Inc — how do they compare? Medpace Holdings Inc trades at $601.2 (market cap $16.90B), while SoFi Technologies Inc trades at $17.86 (market cap $23.22B). The key difference: SoFi Technologies Inc is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, SoFi Technologies Inc nearer its low. Which is the better fit depends on your goals.

MEDPSOFI
Market Cap
$16.90B$23.22B
Sector
TechnologyFinancials
52-Week High
$620.59$32.21
52-Week Low
$393.42$15.15
Enterprise Value
$16.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Medpace Holdings Inc

MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.

Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.

SoFi Technologies Inc

SoFi Technologies (SOFI) trades at $17.82, down 1.66% on the day, with a bullish technical signal from moving averages despite a neutral RSI. The company reported strong Q2 2026 earnings, beating EPS estimates with 40% year-over-year adjusted net revenue growth and record loan originations. Revenue guidance for 2026 was raised to $4.75-$4.85 billion. The stock's valuation shows a P/E of 36.69 and P/S of 5.6, reflecting growth expectations. Analyst consensus is a 'Buy' with a $19.50 price target, though institutional sentiment is mixed with recent position adjustments.

The outlook for SOFI is positive, driven by robust member growth, cross-selling success, and expanding fee-based revenue. Key risks include dependence on interest rate trends, competitive pressures in digital banking, and execution challenges in scaling the technology platform. The stock presents an opportunity for growth investors, but volatility may persist amid macroeconomic uncertainties and investor sensitivity to guidance updates.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Medpace Holdings Inc

Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.

Read more on MEDP

About SoFi Technologies Inc

SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.

Read more on SOFI